Table 6.
Main results regarding expression of Ki67 of included studies.
| Author (year) | Thymectomized patients compared to controls | P value |
|---|---|---|
| Silva et al. (2017b) (28) | ↑ % Ki67+ in naive CD4+
VLT vs controls and VLT vs LT |
<0.0001 (VLT vs controls) 0.0007 (VLT vs LT) |
| Van den Broek et al. (2017) (7) | ↑ % Ki67+ in CD3+ (1-5 years after Tx) NSS % Ki67+ in CD3+ (9 years after Tx) |
<0.05 |
| Zlamy et al. (2016) (29) | ↑ % Ki67+ in CD127+ in memory CD8+ | 0.02 |
| Sauce et al. (2012) (27) | ↑ % Ki67+ in naive CD4+ | 0.01 |
| Van Gent et al. (2011) (16) | ↑ % Ki67+ in naive CD4+ and CD8+ | 0.03 (CD4+); 0.01 (CD8+) |
| Prelog et al. (2009) (23) | % Ki67+ in naive CD4+ (in individuals > 12 years old) 0.4 (0.1-1.7) a vs 0.2 (0.1-0.8) a |
<0.05 |
LT, low TRECs; NSS, not statistically significant; Tx, thymectomy; VLT, very low TRECs.
a
Results are shown as median and ranges in brackets.
↑, higher.